CP

Chandra Phani Kumar Jagarlamudi

Active Director Designated Partner DIN 11840259
DIN 11840259 First appointment Jul 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Chandra Phani Kumar Jagarlamudi

Chandra Phani Kumar Jagarlamudi is a Designated Partner at Unicorn Medical & Healthcare Services Llp (since 2026).

DIN 11840259
Primary Designation Designated Partner
First Appointment 21 Jul 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner21 Jul 20262026Active

Board colleagues of Chandra Phani Kumar Jagarlamudi

Directorship timeline

Open interactive timeline →
Unicorn Medical & Healthcare Services Llp
Premium access

Shareholding and investment profile for Chandra Phani Kumar Jagarlamudi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandra Phani Kumar Jagarlamudi

Chandra Phani Kumar Jagarlamudi currently holds 1 directorship: Unicorn Medical & Healthcare Services Llp (Designated Partner, since 21 Jul 2026).

Chandra Phani Kumar Jagarlamudi was first appointed on 21 Jul 2026 as Designated Partner at Unicorn Medical & Healthcare Services Llp.

The current boards of Chandra Phani Kumar Jagarlamudi's companies include Ada-3029 Ada-3029 (Unicorn Medical & Healthcare Services Llp), Kottakota Bhavani Srinivas (Unicorn Medical & Healthcare Services Llp), Sumanth Addanki (Unicorn Medical & Healthcare Services Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available